KG
Kathleen Goin
Chief Operating Officer

Kathleen Goin insider trades: Palvella Therapeutics (PVLA) stock sales

Chief Operating Officer, Palvella Therapeutics Last trade Oct 21, 2026 14 Form 4 filings
$6.0M
Sold, last 12 months
12 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2025
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Kathleen reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 21, 2026PVLA↓ Sell$537K
Sep 16, 2026PVLA↓ Sell$655K
Aug 19, 2026PVLA↓ Sell$655K
Jul 15, 2026PVLA↓ Sell$642K
Jun 17, 2026PVLA↓ Sell$476K
May 20, 2026PVLA↓ Sell$476K
Apr 15, 2026PVLA↓ Sell$547K
Mar 18, 2026PVLA↓ Sell$508K
Feb 18, 2026PVLA↓ Sell$342K
Jan 21, 2026PVLA↓ Sell$420K
Dec 17, 2025PVLA↓ Sell$415K
Nov 19, 2025PVLA↓ Sell$371K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other PVLA insiders

Open-market trades in the last 12 months

About Kathleen Goin's insider trades

Kathleen Goin is Chief Operating Officer at Palvella Therapeutics (PVLA). Since Nov 19, 2025, Kathleen has reported no open-market purchases and 12 sales worth $6.0M on SEC Form 4. In the last 12 months: 12 sales ($6.0M).

Their filings also include option exercises (12 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PVLA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.